A R T I C L E S
Brask et al.
(126 µL) was added. After further 30 min, TLC (EtOAc-hexane, 2:3)
showed one major component with Rf 0.65. The suspension was
concentrated to dryness and CH3CN (5 mL) was added. Solid N,N′-
diisopropylurea was filtered off and the mixture was purified by prep.
C18 RP-HPLC. Product 3 was obtained as a viscous oil, which
crystallized when a solution in EtOH was poured over ice water. The
crystals were filtered off and dried in vacuo. Yield 142 mg; 62%. m.p.
5.13 (dd, 10.7 Hz, 3.5 Hz, 2H, H-2), 4.8-4.4 (m, 18H, CH2 Aoa/H-5),
4.23 (dd, 11.5 Hz, 7.0 Hz, 2H, H-6a), 4.15 (dd, 11.4 Hz, 5.3 Hz, 2H,
H-6b), 3.72 (s, 4H, CH2S), [1.46, 1.46, 1.42, 1.40] (singlets, 144H,
Boc). 13C NMR (DMSO), δ: [167.9, 167.9, 167.7, 167.1] (CO Aoa),
[153.1, 135.9, 121.8, 119.5] (aryl), [150.6, 150.5, 150.5, 150.5] (CO
Boc), 96.8 (C-1), [84.9, 84.8, 84.8] (C(CH3)3), 73.0 (CH2 Aoa), [69.9,
68.3, 67.9] (C-2/3/4/5), 44.1 (CH2S), [28.7, 28.7, 28.7] (C(CH3)3).
2.a.8. 4-(Mercaptoacetamide)phenyl 2,3,4,6-tetra-O-(Aoa)-r-D-
Galp disulfide, 9. Compound 8 (75 mg, 26 µmol) was deprotected in
TFA/DCM (1:1, 4 mL) for 30 min. The colorless solution was then
concentrated to dryness, dissolved in H2O/CH3CN (10:0.2, 10 mL),
and lyophilized to give template 9 as a white powder. Yield 56 mg;
1
80-83 °C. H NMR (CDCl3), δ: 7.5-7.2 (m, 15H, Tr), 7.20 (d, 9.0
Hz, 2H, aryl), 6.93 (d, 9.0 Hz, 2H, aryl), 5.76 (d, 3.3 Hz, 1H, H-1),
5.70 (dd, 10.7 Hz, 3.2 Hz, 1H, H-3), 5.59 (d, 3.4 Hz, 1H, H-4), 5.27
(dd, 11.1 Hz, 3.9 Hz, 1H, H-2), 4.7-4.4 (m, 9H, CH2 Aoa/H-5), 4.24
(dd, 11.3 Hz, 6.5 Hz, 1H, H-6a), 4.20 (dd, 11.2 Hz, 6.4 Hz, 1H, H-6b),
3.29 (s, 2H, CH2S), [1.55, 1.54, 1.51, 1.50] (singlets, 72H, Boc). 13C
NMR (CDCl3), δ: [167.5, 167.3, 167.1, 167.0] (CO Aoa), 166.5
(NHCO), [153.3, 133.7, 122.0, 118.0] (aryl, OPhNH), [150.7, 150.7,
150.6, 150.5] (CO Boc), [144.5, 130.1, 129.0, 127.9] (aryl, Tr), 95.9
(C-1), [85.2, 85.2, 85.1, 85.0] (C(CH3)3), [72.8, 72.6, 72.5] (CH2 Aoa/
CPh3), [69.4, 69.0, 68.3, 67.6] (C-2/3/4/5), 62.5 (C-6), 37.2 (CH2S),
[28.8, 28.7, 28.7] (C(CH3)3).
1
98% (incl. 8× TFA). H NMR (DMSO, D2O-exch.), δ: 7.54 (d, 8.9
Hz, 4H, aryl), 7.07 (d, 9.3 Hz, 4H, aryl), 5.75 (d, 3.5 Hz, 2H, H-1),
5.6-5.5 (m, 4H, H-3/4), 5.25 (dd, 10.1 Hz, 3.7 Hz, 2H, H-2), 4.7-4.3
(m, 18H, CH2 Aoa/H-5), 4.23 (dd, 11.5 Hz, 7.1 Hz, 2H, H-6a), 4.16
(dd, 11.0 Hz, 5.1 Hz, 2H, H-6b). ESI MS, Calcd for C44H60N10O30S2:
1272.29 Da. Found: m/z 1295.42 [M + Na]+, 1273.42 [M+H]+.
2.a.9. 4HB-Carboprotein Dimer, 10. Template 9 (11 mg, 5.2 µmol)
was dissolved in DMSO (1 mL). Peptide 5 (8 mg, 3.4 µmol) was
dissolved in 0.1 M acetate buffer, pH 4.76 (4 mL). To initiate reaction,
54 µL (0.28 µmol) of the template solution was transferred to the
peptide solution. After 3 h, the mixture was directly injected to prep.
C4 RP-HPLC. After lyophilization of fractions containing product,
carboprotein 10 was obtained as a white powder. Yield 6 mg; 100%
(incl. 32× TFA). ESI MS, Calcd for C764H1260N170O230S2: 16571 Da
(average isotope). Found: m/z 1656.50 [M + 10H]10+, 1506.76 [M +
11H]11+, 1381.64 [M + 12H]12+, 1275.52 [M + 13H]13+, 1184.66 [M
2.a.4. 4-(Mercaptoacetamide)phenyl 2,3,4,6-tetra-O-(Aoa)-r-D-
Galp, 4. Compound 3 (33 mg, 20 µmol) was deprotected in trifluoro-
acetic acid (TFA)/DCM/Et3SiH (1:1:0.1, 4.2 mL) for 1 h. The colorless
solution was then concentrated to dryness, dissolved in DCM (2 mL),
and extracted with H2O (4 × 2 mL). The combined aqueous phases
were freeze-dried to give template 4 as a white powder. Yield 22 mg;
102% (incl. 4× TFA). 1H NMR (D2O), δ: 7.38 (d, 8.8 Hz, 2H, aryl),
7.12 (d, 8.7 Hz, 2H, aryl), 6.02 (d, 3.5 Hz, 1H, H-1), 5.81 (dd, 10.7
Hz, 3.0 Hz, 1H, H-3), 5.74 (d, 2.9 Hz, 1H, H-4), 5.54 (dd, 10.5 Hz,
3.8 Hz, 1H, H-2), 4.8-4.3 (m, 11H, CH2 Aoa/H-5/6), 3.35 (s, 2H,
CH2S). ESI MS, Calcd for C22H31N5O15S: 637.15 Da. Found: m/z
675.97 [M + K]+, 660.01 [M + Na]+, 638.15 [M+H]+.
+ 14H]14+, 1105.77 [M + 15H]15+, 1036.82 [M + 16H]16+
.
2.a.10. N-Phenyl-mercaptoacetamide disulfide, 11. Tritylmercap-
toacetic acid (200 mg, 0.60 mmol) was dissolved in DCM (10 mL).
Aniline (60 µL, 0.66 mmol) was added, followed by DIPCDI (139
µL, 0.90 mmol). After 18 h, the mixture was evaporated to dryness
and the residue dissolved in TFA/DCM/Et3SiH (1:1:0.1, 10.5 mL). After
30 min, the clear solution was again evaporated to dryness. The residue
was dissolved in DMSO/MeCN (1:1, 4 mL) and neutralized with 1 M
KHCO3 (1 mL). The resulting suspension was stirred in an open flask
for 18 h, before being concentrated to 1 mL, dissolved in MeCN (5
mL), and injected to prep. C18 RP-HPLC. Concentration of fractions
gave the title compound as white crystals. Yield 74 mg; 74%. m.p.
2.a.5. 4HB-carboprotein, 6. Template 4 (16 mg, 14.6 µmol) was
dissolved in H2O (2.1 mL). Peptide 5 (10 mg, 4.2 µmol) was dissolved
in MeCN/1 M acetate buffer, pH 4.76 (1:1, 2 mL). To initiate the
reaction, 100 µL (0.70 µmol) of the template solution was transferred
to the peptide solution. After 3 h, the mixture was directly injected to
prep. C4 RP-HPLC. After lyophilization of fractions containing product,
carboprotein 6 was obtained as a white powder. Yield 8 mg; 113%
(incl. 32× TFA). ESI MS, Calcd for C382H631N85O115S: 8287 Da
(average isotope). Found: m/z 1656.84 [M + 5H]5+, 1381.83 [M +
1
157-159 °C (lit. 161-163 °C43). H NMR (CD3OD), δ: 7.57 (d, 8.4
6H]6+, 1184.86 [M + 7H]7+, 1036.96 [M + 8H]8+, 921.86 [M + 9H]9+
829.76 [M + 10H]10+, 754.38 [M + 11H]11+
,
Hz, 4H, aryl), 7.31 (t, 7.3 Hz, 4H, aryl), 7.11 (t, 7.5 Hz, 2H, aryl),
3.68 (s, 4H, COCH2S). ESI MS, Calcd for C16H16N2O2S2: 332.07 Da.
Found: m/z 355.27 [M + H]+, 333.30 [M + Na]+.
.
2.a.6. 4-(Mercaptoacetamide)phenyl r-D-Galp disulfide, 7. Com-
pound 2 (197 mg, 0.34 mmol) was deprotected with TFA/DCM/Et3-
SiH (1:1:0.1, 21 mL) for 30 min. The colorless solution was then
concentrated to dryness, suspended in Et2O (50 mL), and extracted with
H2O (2 × 25 mL). DMSO (5 mL) was added to the aqueous phase.
The solution was stirred for 18 h in an open flask, and then purified
by prep. C18 RP-HPLC. Product 7 was obtained as white needles. Yield
2.b. Analytical Gel Filtration. Gel filtration was performed with a
Superdex 75 HR 10/30 column (Amersham Biosciences, Sweden)
connected to a Waters HPLC system (600 control unit, 996 PDA
detector, 717 Plus autosampler, Millenium 32 control software). A 100-
µL carboprotein sample was injected from a 2 mg/mL solution in 10
mM phosphate, pH 7.0 buffer. Elution buffer was 50 mM phosphate,
100 mM NaCl, pH 7.0. Samples were eluted with 1 mL/min flow rate
and detected by UV absorption at 215 nm. The column was calibrated
with albumin, ovalbumin, chymotrypsinogen A, ribonuclease A,
aprotinin, and vitamin B12.
2.c. Circular Dichroism Spectroscopy. CD spectra were recorded
on a Jasco J-710 instrument at 20 °C (Jasco, Inc., USA). Carboprotein
solutions were 20 µM (carboprotein 6) and 10 µM (carboprotein 10)
in 10 mM NaH2PO4, pH 7.0. The carboprotein concentration was
determined gravimetrically. The mean residue ellipticity was calculated
as [θ] ) θ/(10 × l × c × n), where θ [mdeg] is the measured ellipticity,
l [cm] the path length, c [mol L-1] the carboprotein concentration, and
n the number of amino acid residues in the carboprotein, that is, 60 for
6 or 120 for 10.
1
86 mg; 75%. m.p. 248-250 °C (decomp.). H NMR (DMSO, D2O-
exch.), δ: 7.46 (dd, 1.8 Hz, 6.5 Hz, 4H, aryl), 7.02 (dd, 2.2 Hz, 6.8
Hz, 4H, aryl), 5.30 (d, 2.3 Hz, 2H, H-1), 3.8-3.3 (m, 16H, H-2/3/4/
5/6/CH2S). 13C NMR (DMSO), δ: 167.5 (NHCO), [154.6, 134.0, 121.8,
118.6] (aryl), 99.8 (C-1), 73.2 (C-5), [70.4, 69.6, 69.1] (C-2/3/ 4), 61.4
(C-6), 44.1 (CH2S).
2.a.7. 4-(Mercaptoacetamide)phenyl 2,3,4,6-tetra-O-(Boc2-Aoa)-
r-D-Galp disulfide, 8. Compound 7 (80 mg, 0.12 mmol) and Boc2-
Aoa-OH (338 mg, 1.16 mmol) were suspended in pyridine/DCM (1:1,
4 mL). DMAP (14 mg, 0.12 mmol) and DIPCDI (180 µL, 1.16 mmol)
were added. Additional DIPCDI (2 × 180 µL) was added in two
portions during the next 4 h,. After a further 16 h, the suspension was
concentrated to dryness and CH3CN (5 mL) was added. Solid N,N′-
diisopropylurea was filtered off and the mixture was purified by prep.
C18 RP-HPLC. Product 8 was obtained as a clear, colorless oil. Yield
86 mg; 26%. 1H NMR (DMSO), δ: 7.56 (d, 8.8 Hz, 4H, aryl), 7.04 (d,
8.8 Hz, 4H, aryl), 5.67 (d, 3.4 Hz, 2H, H-1), 5.6-5.5 (m, 4H, H-3/4),
2.d. Preparation of Samples for Voltammetry, In Situ STM, and
XPS. Single-crystal gold bead electrodes for voltammetry and capaci-
(43) Schimelpfenig, C. W. J. Org. Chem. 1962, 27, 3323-3324.
9
96 J. AM. CHEM. SOC. VOL. 125, NO. 1, 2003